Download full-text PDF |
Source |
---|
Transpl Int
December 2024
Finnish Red Cross Blood Service, Helsinki, Finland.
HLA typing and matching have been crucial in kidney transplantation, but methods for assessing tissue histocompatibility have advanced significantly. While serological-level HLA typing remains common, it captures only a small fraction of true HLA variation, and molecular matching is already replacing traditional HLA matching. Recent studies have expanded our understanding of genetic tissue compatibility beyond HLA loci.
View Article and Find Full Text PDFTissue Cell
December 2024
Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address:
In the medical field, wound healing poses significant challenges due to its complexity and time-consuming nature. Cell-free wound repair, notably the utilization of exosomes (EXOs), has made significant progress in recent years. Urine, saliva, umbilical cord, blood, mesenchymal stem cells and breast milk cells can be used to extract and purify EXOs, which are Nano-sized lipid bilayer vesicles.
View Article and Find Full Text PDFJ Clin Immunol
November 2024
Department of Human Genetics, Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon.
Endophilin A2, the sole endophilin A family member expressed in hematopoietic cells, regulates various aspects of membrane dynamics, including autophagy and endocytosis. Recent studies in rodents highlight the essential role of endophilin A2 in modulating immune responses. Here we report a homozygous frameshift variant in the SH3GL1 gene (NM_003025.
View Article and Find Full Text PDFJ Allergy Clin Immunol Pract
October 2023
Program of Immunogenetics and Translational Immunology, Facultad de Medicina, Clínica Alemana Universidad del Desarrollo, Santiago, Chile; Hospital de niños Dr. Roberto del Rio, Santiago, Chile.
Inborn errors of immunity represent a rapidly expanding group of genetic disorders of the immune system. Significant advances have been made in recent years in diagnosis, including using genetic testing and newborn screening; treatment, including precision therapies, gene therapy and hematopoietic stem cell transplant; and development of patient registries to inform prevalence, understand morbidity of these disorders and guide the development of clinical trials. However, significant disparities due to age, race, ethnicity, socioeconomic status, or geographic location exist in all aspects of care of patients with inborn errors of immunity, beginning with delays in diagnosis and further compounded by impaired access to specialist care and treatment, leading to a notable impact on outcomes including morbidity and mortality.
View Article and Find Full Text PDFFront Immunol
October 2024
Department of Internal Medicine, Division of Rheumatology, Marmara University School of Medicine, Istanbul, Türkiye.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!